Dr. Joseph Nathan, ForSight Robotics: Democratising Quality Surgical Eye Care Worldwide
ForSight Robotics is focused on advancing surgical eye care through the development of the ORYOM™ Platform, a robotic surgery system designed to address cataracts and other eye diseases. The platform aims to provide standardized, high-quality surgical…
ForSight Robotics is focused on advancing surgical eye care through the development of the ORYOM™ Platform, a robotic surgery system designed to address cataracts and other eye diseases. The platform aims to provide standardized, high-quality surgical care to a global patient base.
The company has completed over 200 cataract procedures using animal eye models, involving more than 25 surgeons. Clinical trials are scheduled to commence in the upcoming year, with an objective to improve accessibility to sight-saving surgeries globally.
ForSight Robotics has assembled a team of experts in robotic surgery, ophthalmology, and AI. Recent advancements include gaining ISO 13485:2016 certification, expanding their team, and appointing Dr. Fred Moll to the Board of Directors.
The platform aims to provide standardized, high-quality surgical care to a global patient base.
The ORYOM™ Platform is engineered to handle both anterior and posterior eye surgeries. While initially targeting cataract procedures, the platform may extend to glaucoma and retinal surgeries, enhancing comprehensive ophthalmic care.
With over 1.1 billion individuals affected by preventable vision impairment, the introduction of robotics in ophthalmology seeks to bridge the gap in surgical care. The integration of robotic systems aims to reduce surgeon training time and improve surgical outcomes globally.
Based on reporting by techround.co.uk.
